ADT-OH inhibits the activation of NF-κB in B16F10 melanoma cells, reduces the expression of downstream target genes of NF-κB pathway (e.g. XIAP, Bcl-2), and induces cell apoptosis via mitochondrial pathway. Here, BCL2 is linked to melanoma.